← Browse by Condition
Medical Condition

locally advanced inoperable or metastatic breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT04862663 Phase 3
Recruiting

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Enrollment
895 pts
Location
United States, Argen...
Sponsor
AstraZeneca
View Trial →